Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA slashes price of...

    NPPA slashes price of 39 drugs: check out details

    Written by Ruby Khatun Khatun Published On 2017-09-21T10:34:56+05:30  |  Updated On 18 Aug 2021 3:15 PM IST

    New Delhi: Drug price regulator NPPA on Wednesday said it has fixed the ceiling price for 39 more drug formulations, including those used for the treatment of cancer, tuberculosis, malaria and hepatitis B among others.


    The National Pharmaceutical Pricing Authority (NPPA) said while the ceiling price of 18 scheduled formulations has been fixed, that of 21 has been revised.

    "The NPPA has fixed/revised ceiling prices of 39 scheduled formulations of Schedule-I under Drugs (Prices Control) Order, 2013...," the regulator said in a notification.


    With the latest price revision, the prices of around 821 formulations that are on the national list of essential medicines (NLEM) 2015, have been capped, the NPPA said in a tweet.

    The steps are in continuation of the government's drive to make affordable quality medicines available to patients across the country.

    According to a senior government official, the normal range of reduction is between 10-30 percent.

    The NPPA is mandated to fix/revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country.

    It also monitors the prices of decontrolled drugs in order to keep them at reasonable levels.

    The regulator implements and enforces the provisions of the Drugs (Prices Control) Order.

    The regulator is also entrusted with the task of recovering amounts overcharged by manufacturers for the controlled drugs from the consumers.

    Medical Dialogues had earlier reported that NPPA had fixed/revised ceiling prices/Retail Prices of 9 scheduled formulations of Schedule-I under Drugs (Price Control) Order 2013, exclusive of goods and services tax (GST).


    Read also: NPPA fixes ceiling prices of 9 scheduled formulations, check out details

    39 drugscancerDrugs Prices Control OrderGoods and Services TaxGSThepatitis BmalariaNational List of Essential MedicinesNational Pharmaceutical Pricing AuthorityNLEMNPPANPPA cuts Drug PricesNPPA FIxes Ceiling PricepriceslashesTuberculosis
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok